|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 18 April 2006
doi: 10.1242/jcs.02913
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 RIKEN Bioresource Center, Tsukuba, Ibaraki 305-0074, Japan
2 Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Chiba 277-8562, Japan
* Author for correspondence (e-mail: ogura{at}rtc.riken.go.jp)
Accepted 1 February 2006
| Summary |
|---|
|
|
|---|
Key words: Embryos, Hematopoietic stem cells, Mice, Nuclear transfer, Zygotic gene activation
| Introduction |
|---|
|
|
|---|
Hematopoietic stem cells (HSCs) are the longest-studied and best-understood mammalian adult stem cells. Recently established methodology for the purification of HSCs enables the direct and precise examination of their biological and biochemical properties, especially those related to self-renewal and differentiation (reviewed by Ema and Nakauchi, 2003
; Akashi, 2005
). At present, it is known that even a single HSC can fully reconstitute the hematopoietic compartment of lethally irradiated adult mice, indicating that the purification of HSCs does not perturb their biological normality and stem cell features (Osawa et al., 1996
). Furthermore, although still controversial, recent studies have reported that the genomic plasticity of HSCs enables them to switch between hematopoietic and non-hematopoietic lineages (Krause et al., 2001
; Wagers et al., 2002
). Therefore, it is expected that these purified HSCs could be used as nuclear donors because they have a relatively undifferentiated genome, which is considered better for somatic cell cloning than that of differentiated cells. In this study, we examined the reprogramming efficiency of the HSC genome after nuclear transfer cloning. It is known that the complexity of potentially contributory technical factors associated with cloning experiments might obscure the reprogramming efficiency of the donor genome. Therefore, we carefully assessed embryos reconstructed with HSCs for their developmental ability in vitro and in vivo, and for gene expression patterns, and compared these with those of embryos reconstructed with other somatic cells (cumulus cells, immature Sertoli cells and fibroblast cells) of the defined genetic backgrounds under strictly controlled experimental conditions as described previously (Inoue et al., 2002
; Inoue et al., 2003
).
| Results and Discussion |
|---|
|
|
|---|
|
|
Transcription activity and gene expression in HSC clone embryos
As shown in the preceding section, the earliest developmental arrest of HSC embryos was found at the transition from 2-cell to 4-cell stage. In general, the donor genome should be reprogrammed by nuclear transfer to activate embryo-specific genes at the appropriate time, as occurs in normal fertilized embryos. This switch from maternal to embryonic control of the genome is commonly referred to as zygotic (or embryonic) gene activation (ZGA or EGA). In mice, early minor ZGA has been observed in the late 1-cell stage but the major ZGA occurs at the 2-cell stage (Telford et al., 1990
). Therefore, it is very likely that reconstructed mouse embryos would arrest their development if they failed to initiate ZGA in a proper manner. To elucidate this possibility, we first examined transcriptional activity in HSC clone embryos for the initial ZGA (12 hours after oocyte activation) using a 5-bromouridine 5'-triphosphate (BrUTP) incorporation assay (Kim et al., 2002
). As shown in Fig. 2, the levels of anti-BrUTP fluorescence, which reflect the transcriptional activity in HSC clone embryos, were not significantly different from those of control parthenogenetic or cumulus clone embryos. This indicates that HSC clone embryos initiated ZGA normally in terms of its timing and the initial transcriptional level; in other words, they successfully activated the so-called `zygotic clock'.
|
The result from the BrUTP incorporation assay did not preclude the possibility that the developmental arrest of HSC clones might have been caused by failure to activate genes of the major ZGA at the 2-cell stage. We selected six zygotic genes - Dppa2, Dppa3, Dppa4, ERV-L, Hdac1 and eIF-1A - according to previous studies on global or specific gene expression analysis (De Sousa et al., 1998
; Hamatani et al., 2004
; Evsikov et al., 2004
). We examined individual embryos because cloned embryos generally show diverse gene expression patterns, even under strictly controlled experimental condition. The transcription levels of these genes in each embryo were examined by real-time quantitative reverse transcriptase (RT)-PCR using specific primers (Table S1, supplementary material). The gene expression patterns of HSC cell embryos, cumulus cell embryos, in vitro fertilization (IVF) embryos and metaphase II (MII) oocytes are summarized in Fig. 3. Of the genes examined, Dppa2, Dppa3, ERV-L and eIF-1A showed significantly lower expression levels in HSC and cumulus clone embryos than in IVF embryos (Fig. 3). By contrast, Hdac1 was downregulated in HSC clone embryos and normally expressed in cumulus clone embryos (Fig. 3).
|
-amanitin among the histone deacetylase genes and has the most number of interactions with other genes in a gene network of mouse 2-cell embryos (Zeng and Schultz, 2005
We then examined whether the levels of histone acetylation were affected in HSC clone embryos by immunostaining using antibodies specific to histone H3 acetylated on lysine 9 (H3K9), histone H4 acetylated on lysine 8 (H4K8) and histone H3 acetylated on lysine 14 (H3K14). According to data by Stein et al. (Stein et al., 1997
), H3K9 and H4K8 are sensitive to histone deacetylase inhibitors whereas H3K14 is non-sensitive. As expected, HSC clone embryos were more strongly stained with the antibodies for H3K9 and H4K8, but not with the antibody for H3K14, as compared with cumulus clone embryos and intracytoplasmic sperm injection (ICSI) embryos (Fig. 4). This finding clearly indicates that the low Hdac1 activity in HSC clone embryos leads to a phenotypic modification at the chromatin level, and probably leads to low developmental potency of the embryos. Interestingly, Kishigami et al. have recently reported that development of clones was significantly improved when reconstructed oocytes were exposed to trichostatin A during oocyte activation (Kishigami et al., 2006
). As the zygotic transcription has not yet started by this stage, this treatment might have enhanced reprogramming of the genome by increasing the accessibility of `reprogramming factors' to DNA with hyperacetylated histones.
|
The expression of Dppa2, Dppa3, ERV-L and eIF-1A was significantly repressed in both HSC and cumulus clone embryos as compared with that of IVF embryos (Fig. 3). The eIF-1A gene is also a key regulator of ZGA because eIF-1A (formerly known as eIF-4C) is the major translation initiation factor in mouse 2-cell embryos and is thought to function in mRNA and initiator tRNA recruitment (Rhoads, 1993
; De Sousa et al., 1998
). Dppa2 and Dppa3 are genes with sequence similarities to the Oct4 gene, which plays an essential role in the control of developmental pluripotency. Dppa3, also known as PGC7 (Sato et al., 2002
) and Stella (Saitou et al., 2002
), is essentially a maternal-effect gene but is further activated during preimplantation development (Payer et al., 2003
). ERV-L is an endogenous retrovirus gene that shows a high expression coincidently with ZGA, although its roles in embryonic development are unclear (Evsikov et al., 2004
). It is very probable that these zygotically activated genes had a cumulative effect and were responsible, at least in part, for the lower development potential of cloned embryos compared with normally fertilized IVF embryos (more than 90% blastocyst rates). We postulate that the low Hdac1 activity found in HSC clone embryos might have further compromised their gene expression pattern, leading to the extremely low cloning efficiency.
Unlike normal fertilization, successful nuclear transfer cloning requires silencing of genes that had been actively transcribed in the donor cells. In a recent study of cloning cultured myoblast cells, the reconstructed embryos continued to express muscle-specific genes and showed a greater preference for cell culture media than embryo culture media, indicating inheritance of somatic cell phenotypes (Gao et al., 2003
). We examined HSC clone embryos for the transcription of Endomucin, CD45 and c-kit, which are known to represent active genes of HSCs (Akashi et al., 2003
). RT-PCR revealed that these genes were not expressed in HSC clone embryos at the 2-cell or blastocyst stage (Fig. 5). The absence of CD45 protein was also confirmed by immunofluorescence of HSC-derived blastocysts (data not shown). Normal gene suppression upon nuclear transfer was also confirmed for cumulus cell clones (Fig. 5). Thus, we can assume that the active state of donor-specific genes was successfully converted to the repressive state following nuclear transfer under our experimental conditions.
|
The extremely low cloning outcome using HSCs as donor cells is in contrast with the efficient birth of clone pups and establishment of ES cells following nuclear transfer with NKT cells, a lymphocyte population in the same hematopoietic lineage (Inoue et al., 2005
). Therefore, the presumptive notion that there is a reciprocal correlation between nuclear transfer cloning efficiency and cell differentiation status might not always be true, at least for cells within the hematopoietic lineage.
Why was Hdac1 repressed in HSC clone embryos?
As mentioned previously in this paper, low Hdac1 activity might have been one of the causes of the very poor development of HSC clone embryos. Generally, hyperacetylation of histones results in a transcriptionally active state by increasing the accessibility of transcriptional factors to DNA (Grunstein, 1997
). This state can be readily achieved by low histone deacetylase activity. It is hypothesized that HSCs express multiple genes at a low level, probably as a result of a wide-open chromatin structure that enables random access of multiple transcriptional factors (Akashi et al., 2005; Zipori, 2004
). HSCs decrease transcriptional accessibility as they differentiate in a stepwise manner to restrict the developmental potentials (Akashi et al., 2003
). In an additional series of experiments, we undertook a quantitative analysis for Hdac1 expression in donor HSCs that were freshly prepared from bone marrow tissue. Interestingly, the expression of Hdac1 mRNA in HSCs was lower than that of other somatic cells (Fig. 6). Indeed, a recent study presented evidence that histone deacetylase inhibitors can preserve stem cell characteristics in mouse and human HSCs in culture (Young et al., 2004
). Thus, the epigenetic state of the HSC genome, which might reflect its stem-like nature, is perhaps resistant to reprogramming and could be inherited through nuclear transfer, although further analytical studies are needed to confirm this hypothesis.
|
| Materials and Methods |
|---|
|
|
|---|
Nuclear donor cells
HSCs, cumulus cells, immature Sertoli cells and fibroblast cells were prepared as described previously (Osawa et al., 1996
; Wakayama et al., 1998
; Ogura et al., 2000a
; Ogura et al., 2000b
) with slight modifications. HSCs were isolated from the bone marrow of 8- to 10-week-old B6D2F1 and (B6x129)F1 mice. Bone marrow cells were stained with a lineage marker (Lin) cocktail consisting of biotinylated anti-Gr-1, -Mac-1, -B220, -CD4, -CD8 and -Ter119 antibodies. Lin+ cells were depleted using Dynabeads M-280 streptavidin (SA) (Dynal Biotech). The remaining cells were stained with fluorescein isothiocyanate (FITC)-conjugated anti-CD34, phycoerythrin (PE)-conjugated anti-Sca-1, allophycocyanin (APC)-conjugated anti-c-Kit and biotinylated anti-Lin antibodies, followed by staining with SA-APC-Cy7. CD34-/lowc-Kit+Sca-1+Lin- (CD34-KSL) cells, which are highly enriched for HSCs, were sorted into 200 µl of serum-free medium S-Clone (Sanko Junyaku) containing 1% fetal bovine serum, mouse stem cell factor (SCF) (10 ng/ml; KIRIN), and human thrombopoietin (TPO; 100 ng/ml; KIRIN) using a fluorescence-activated cell sorter (FACS) Vantage SE (BD Biosciences). All antibodies were purchased from BD Biosciences Pharmingen and eBioscience. The sorting gates for CD34-KSL cells on FACS profiles are shown in Fig. S1, supplementary material. CD34-KSL cells represented 0.0154%±0.0057% and 0.0106%±0.0016% of bone marrow mononuclear cells in B6D2F1 (n=8) and (B6x129)F1 (n=6) mice, respectively. The sorted CD34-KSL cells were subjected to a competitive repopulation assay (Osawa et al., 1996
). Cumulus cells were collected from cumulus-oocyte complexes of B6D2F1 mice that had been superovulated, as described below. Immature Sertoli cells were isolated from newborn testes of (B6x129)F1 males at 2-5 days after birth by treatment with 0.1 mg/ml collagenase (Sigma Aldrich) and 0.2 mg/ml trypsin (Sigma Aldrich). Adult fibroblast cells were collected from tail-tip tissue of B6D2F1 females and (B6x129)F1 males at 2-4 months of age. Tail-tip fibroblasts adhered to the bottom of the dish and became confluent within two weeks of culture.
Nuclear transfer
Nuclear transfer was carried out as described previously (Wakayama et al., 1998
; Ogura et al., 2000a
; Ogura et al., 2000b
). B6D2F1 females at 7-10 weeks of age were superovulated with an injection of 7.5 IU pregnant mare serum gonadotrophin (PMSG) and 7.5 IU human chorionic gonadotropin (hCG) at intervals of 48 hours. Mice were sacrificed and the oviducts were removed 16 hours after the hCG injection. Cumulus-oocyte complexes collected from the oviducts were freed of cumulus cells by 0.1% bovine testicular hyaluronidase in KSOM medium (Lawitts and Biggers, 1993
). Oocytes were washed three times with fresh KSOM medium and were incubated at 37.5°C in an atmosphere of 5.5% CO2 in air. MII oocytes were enucleated with a small amount of cytoplasm in Hepes-buffered KSOM medium containing 7.5 mg/ml cytochalasin B at 37°C using a piezo-driven micromanipulator (PrimeTech). After repeated washes with fresh medium, the enucleated oocytes were incubated in KSOM for 0.5-2 hours. Nuclei from hematopoietic cells, cumulus cells and immature Sertoli cells were transferred into enucleated oocytes by direct injection using a piezo-driven micromanipulator. Nuclei from tail-tip fibroblasts were transferred by electrofusion (2300 V/cm, 9 µs) in 300 mM mannitol medium containing 50 nm MgCl2 and 0.1 mg/ml polyvinyl alcohol. Oocyte-donor cell pairs were aligned by AC current (200 V/cm, 2 MHz, 10-20 seconds) before the electrofusion pulse. Oocytes reconstructed by injection or electrofusion were cultured in KSOM for 1-2 hours, activated with Ca2+-free KSOM containing 3 mM SrCl2 and 5 mg/ml cytochalasin B for 1 hour, and then cultured in the presence of 5 mg/ml cytochalasin B for 5 hours. After washing, the embryos were further cultured in KSOM at 37.5°C under 5.5% CO2 in air until gene expression analysis or embryo transfer. Reconstructed embryos that reached the 4-cell stage by 48 hours in culture were transferred into the oviducts of day-one pseudopregnant ICR females mated with vasectomized males. On day 20, the recipient females were examined for the presence of fetuses, and live pups were nursed by lactating ICR females.
Measurement of in vitro transcriptional activity
In vitro transcriptional activity was measured as described previously (Kim et al., 2002
). Briefly, reconstructed embryos at 12 hours post-activation were permeabilized in phosphate buffer (PB) containing 0.05% Triton X-100 and labeled with BrUTP for 15 minutes. After washing with PB three times, the embryos were fixed with 3.7% paraformaldehyde and stained with anti-BrUTP monoclonal antibody (Boehringer-Mannheim). Subsequently, they were incubated in PBS containing 0.5 mg/ml anti-mouse IgG antibody conjugated with Texas Red (Jackson ImmunoResearch) for 45 minutes. Fluorescent label was quantified with a confocal laser-scanning microscope (Carl Zeiss).
Gene expression analysis of 2-cell and blastocyst embryos
The zonae pellucidae of reconstructed 2-cell stage (24-26 hours after activation) or blastocyst (96-98 hours after activation) embryos were removed by treatment with acidic Tyrode's solution. Each embryo was transferred into a 0.2 ml PCR tube, and cDNA was extracted by Cell-to-cDNA II (Ambion). For primer sequences and PCR conditions, see supplementary material. For quantitative analysis using 2-cell embryos, the PCR products amplified with primers were purified with a Freeze `N Squeeze Spin Column (BioRad) and tenfold serially diluted products were used as the external standards for the real-time PCR. The ABI Prism 7900HT was used to determine the levels of cDNA with a QuantiTect SYBER Green PCR Kit (QIAGEN). The level of the Hprt gene in each embryo was used for the endogenous reference. Temperature conditions for amplification were as follows: an initial activation step of 94°C for 15 minutes, followed by 50 cycles of denaturation at 94°C for 30 seconds, annealing at 60°C for 30 seconds and extension at 72°C for 30 seconds, and a final step at 72°C for 2 minutes. For the gene expression analysis of blastocysts, purified cDNAs were amplified with Ex Taq DNA Polymerase Hot-Start Version (TaKaRa) using the primer sets listed in Table S1, supplementary material. The amplified products were separated by 2% agarose gel electrophoresis.
Expression analysis of donor-cell-specific genes in cloned embryos
Tissue and cell samples (liver, kidney, cumulus cells and HSCs) for gene expression analysis were collected from B6D2F1 adult females. Immediately before collection of the liver and kidneys, cells in the blood vessels were thoroughly removed by perfusion of animals under deep anesthesia. Cumulus cells and HSCs were prepared as described elsewhere in the methods section. After homogenization, RNAs of these samples were purified with ISOGEN (Wako). cDNAs were synthesized with reverse transcriptase (Takara) and quantitative analysis was carried out as described above with primers shown in Table S1, supplementary material.
Immunostaining for acetylated histones in 2-cell embryos
2-cell embryos were fixed in PBS containing 0.1 mg/ml polyvinyl alcohol and 4% paraformaldehyde for 1 hour and washed in PBS supplemented with 1 mg/ml BSA (Sigma-Aldrich) (PBS-BSA) at room temperature. Fixed embryos were then immersed overnight with PBS-BSA containing 0.5% Triton X-100 for blocking and permeabilization at 4°C. The embryos were incubated with a rabbit polyclonal antibody against acetyl-histone H3-Lys9 (H3K9), H3-Lys14 (H3K14) or K4-Lys8 (H4K8) (Upstate) for 1 hour. After washing in PBS-BSA, the embryos were stained with FITC-conjugated anti-rabbit IgG antibody (Sigma-Aldrich) for 1 hour. For labeling nuclear DNA, 5 mg/ml DAPI (Nacalai Tesque) was used. Immunostaining was performed at room temperature. Following thorough washing, the embryos were mounted on slide glasses using antifading mounting medium (Vectashield; Vector Laboratories) and observed using a confocal scanning laser microscope (Digital Eclipse C1).
Statistical analysis
Development of embryos in vitro and in vivo was compared between groups using Fisher's exact probability test. The relative transcription levels of embryos or donor cells determined by quantitative real-time RT-PCR were analyzed by one-way ANOVA followed by a post-hoc procedure using Scheffe's F test for multiple comparisons between the groups where appropriate. Other methods of statistical analysis, when appropriate, are indicated in the Results and Discussion.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Akashi, K. (2005). Lineage promiscuity and plasticity in hematopoietic development. Ann. N. Y. Acad. Sci. 1044, 125-131.
Akashi, K., He, X., Chen, J., Iwasaki, H., Niu, C., Steenhard, B., Zhang, J., Haug, J. and Li, L. (2003). Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101, 383-389.
De Sousa, P. A., Watson, A. J. and Schultz, R. M. (1998). Transient expression of a translation initiation factor is conservatively associated with embryonic gene activation in murine and bovine embryos. Biol. Reprod. 59, 969-977.
Eggan, K., Akutsu, H., Loring, J., Jackson Grusby, L., Klemm, M., Rideout, W. M., III, Yanagimachi, R. and Jaenisch, R. (2001). Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. USA 98, 6209-6214.
Ema, H. and Nakauchi, H. (2003). Self-renewal and lineage restriction of hematopoietic stem cells. Curr. Opin. Genet. Dev. 13, 508-512.[Medline]
Evsikov, A. V., de Vries, W. N., Peaston, A. E., Radford, E. E., Fancher, K. S., Chen, F. H., Blake, J. A., Bult, C. J., Latham, K. E., Solter, D. et al. (2004). Systems biology of the 2-cell mouse embryo. Cytogenet. Genome Res. 105, 240-250.[CrossRef][Medline]
Gao, S., Chung, Y. G., Williams, J. W., Riley, J., Moley, K. and Latham, K. E. (2003). Somatic cell-like features of cloned mouse embryos prepared with cultured myoblast nuclei. Biol. Reprod. 69, 48-56.
Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.[CrossRef][Medline]
Hamatani, T., Carter, M. G., Sharov, A. A. and Ko, M. S. (2004). Dynamics of global gene expression changes during mouse preimplantation development. Dev. Cell 6, 117-131.[CrossRef][Medline]
Hochedlinger, K. and Jaenisch, R. (2002). Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415, 1035-1038.[CrossRef][Medline]
Inoue, K., Kohda, T., Lee, J., Ogonuki, N., Mochida, K., Noguchi, Y., Tanemura, K., Kaneko-Ishino, T., Ishino, F. and Ogura, A. (2002). Faithful expression of imprinted genes in cloned mice. Science 295, 297.
Inoue, K., Ogonuki, N., Mochida, K., Yamamoto, Y., Takano, K., Kohda, T., Ishino, F. and Ogura, A. (2003). Effects of donor cell type and genotype on the efficiency of mouse somatic cell cloning. Biol. Reprod. 69, 1394-1400.
Inoue, K., Wakao, H., Ogonuki, N., Miki, H., Seino, K., Nambu-Wakao, R., Noda, S., Miyoshi, H., Koseki, H., Taniguchi, M. et al. (2005). Generation of cloned mice by direct nuclear transfer from natural killer T cells. Curr. Biol. 15, 1114-1118.[CrossRef][Medline]
Ito, M., Sakai, S., Nagata, M. and Aoki, F. (2000). Effect of histone deacetylase inhibitors on early preimplantation development in mouse embryo. J. Mammal. Ova Res. 17, 90-95.[CrossRef]
Kim, J. M., Ogura, A., Nagata, M. and Aoki, F. (2002). Analysis of the mechanism for chromatin remodeling in the embryos reconstructed by somatic nuclear transfer. Biol. Reprod. 67, 760-766.
Kishigami, S., Mizutani, E., Ohta, H., Hikichi, T., Thuan, N. V., Wakayama, S., Bui, H. T. and Wakayama, T. (2006). Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem. Biophys. Res. Commun. 340, 183-189.[Medline]
Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., Neutzel, S. and Sharkis, S. J. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369-377.[CrossRef][Medline]
Lawitts, J. A. and Biggers, J. D. (1993). Culture of preimplantation embryos. Methods Enzymol. 225, 153-164.[Medline]
Ma, J., Svoboda, P., Schultz, R. M. and Stein, P. (2001). Regulation of zygotic gene activation in the preimplantation mouse embryo: global activation and repression of gene expression. Biol. Reprod. 64, 1713-1721.
Miki, H., Inoue, K., Kohda, T., Honda, A., Ogonuki, N., Yuzuriha, M., Mise, N., Matsui, Y., Baba, T., Abe, K. et al. (2005). Birth of mice produced by germ cell nuclear transfer. Genesis 41, 81-86.[CrossRef][Medline]
Ogura, A., Inoue, K., Ogonuki, N., Noguchi, A., Takano, K., Nagano, R., Suzuki, O., Lee, J., Ishino, F. and Matsuda, J. (2000a). Production of male clone mice from fresh, cultured, and cryopreserved immature Sertoli cells. Biol. Reprod. 62, 1579-1584.
Ogura, A., Inoue, K., Takano, K., Wakayama, T. and Yanagimachi, R. (2000b). Birth of mice after nuclear transfer by electrofusion using tail tip cells. Mol. Reprod. Dev. 57, 55-59.[CrossRef][Medline]
Osawa, M., Hanada, K., Hamada, H. and Nakauchi, H. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245.[Abstract]
Payer, B., Saitou, M., Barton, S. C., Thresher, R., Dixon, J. P., Zahn, D., Colledge, W. H., Carlton, M. B., Nakano, T. and Surani, M. A. (2003). Stella is a maternal effect gene required for normal early development in mice. Curr. Biol. 13, 2110-2117.[CrossRef][Medline]
Rhoads, R. E. (1993). Regulation of eukaryotic protein synthesis by initiation factors. J. Biol. Chem. 268, 3017-3020.
Saito, S., Sawai, K., Ugai, H., Moriyasu, S., Minamihashi, A., Yamamoto, Y., Hirayama, H., Kageyama, S., Pan, J., Murata, T. et al. (2003). Generation of cloned calves and transgenic chimeric embryos from bovine embryonic stem-like cells. Biochem. Biophys. Res. Commun. 309, 104-113.[CrossRef][Medline]
Saitou, M., Barton, S. C. and Surani, M. A. (2002). A molecular programme for the specification of germ cell fate in mice. Nature 418, 293-300.[CrossRef][Medline]
Sato, M., Kimura, T., Kurokawa, K., Fujita, Y., Abe, K., Masuhara, M., Yasunaga, T., Ryo, A., Yamamoto, M. and Nakano, T. (2002). Identification of PGC7, a new gene expressed specifically in preimplantation embryos and germ cells. Mech. Dev. 113, 91-94.[CrossRef][Medline]
Schultz, R. M., Davis, W., Jr, Stein, P. and Svoboda, P. (1999). Reprogramming of gene expression during preimplantation development. J. Exp. Zool. 285, 276-282.[CrossRef][Medline]
Stein, P., Worrad, D. M., Belyaev, N. D., Turner, B. M. and Schultz, R. M. (1997) Stage-dependent redistributions of acetylated histones in nuclei of the early preimplantation mouse embryo. Mol. Reprod. Dev. 47, 421-429.[CrossRef][Medline]
Tamada, H. and Kikyo, N. (2004). Nuclear reprogramming in mammalian somatic cell nuclear cloning. Cytogenet. Genome Res. 105, 285-291.[CrossRef][Medline]
Telford, N. A., Watson, A. J. and Schultz, G. H. (1990). Transition from maternal to embryonic control in early mammalian development; a comparison of several species. Mol. Reprod. Dev. 26, 90-100.[CrossRef][Medline]
Wagers, A. J., Sherwood, R. I., Christensen, J. L. and Weissman, I. L. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297, 2256-2259.
Wakayama, T., Perry, A. C. F., Zuccotti, M., Johnson, K. R. and Yanagimachi, R. (1998). Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394, 369-374.[CrossRef][Medline]
Wakayama, T., Mombaerts, P., Rodriguez, I., Perry, A. C. F. and Yanagimachi, R. (1999). Mice cloned from embryonic stem cells. Proc. Natl. Acad. Sci. USA 96, 14984-14989.
Young, J. C., Wu, S., Hansteen, G., Du, C., Sambucetti, L., Remiszewski, S., O'Farrell, A. M., Hill, B., Lavau, C. and Murray, L. J. (2004). Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy 6, 328-336.[Medline]
Zeng, F. and Schultz, R. M. (2005). RNA transcript profiling during zygotic gene activation in the preimplantation mouse embryo. Dev. Biol. 283, 40-57.[CrossRef][Medline]
Zipori, D. (2004). The nature of stem cells: state rather than entity. Nat. Rev. Genet. 5, 873-878.[Medline]
This article has been cited by other articles:
![]() |
A.L Green, D.N Wells, and B Oback Cattle Cloned from Increasingly Differentiated Muscle Cells Biol Reprod, September 1, 2007; 77(3): 395 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K Berg, C. Li, G. Asher, D. N Wells, and B. Oback Red Deer Cloned from Antler Stem Cells and Their Differentiated Progeny Biol Reprod, September 1, 2007; 77(3): 384 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue, S. Noda, N. Ogonuki, H. Miki, S. Inoue, K. Katayama, K. Mekada, H. Miyoshi, and A. Ogura Differential Developmental Ability of Embryos Cloned from Tissue-Specific Stem Cells Stem Cells, May 1, 2007; 25(5): 1279 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, V. Greco, G. Guasch, E. Fuchs, and P. Mombaerts Mice cloned from skin cells PNAS, February 20, 2007; 104(8): 2738 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mizutani, H. Ohta, S. Kishigami, N. Van Thuan, T. Hikichi, S. Wakayama, M. Kosaka, E. Sato, and T. Wakayama Developmental ability of cloned embryos from neural stem cells. Reproduction, December 1, 2006; 132(6): 849 - 857. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||